Chronic fatigue in diabetic patients can be the outcome of protein deficiency. Plant based protein is closer to nature and bodily acceptable, hence we chose to assess plant-based protein “Balya Protex Powder” over whey protein. A prospective, multicentre, post-market study was conducted in India. Patients with a diagnosis of diabetes mellitus aged 18 years and above were included in this study. All patients adhered to the Comprehensive Diabetic Care (CDC) Program. Comparative data of change in fatigue score was collected retrospectively from type 2 diabetes mellitus patients assigned a low carbohydrate low calorie diet for 90 days. A total of 101 patients were included in this study, 50 patients consumed the Balya Protex Powder whilst 51 did not consume the Balya Protex powder whilst adhering to the CDC program. Weight of the patients decreased by 7.92% and 5.52% in the Balya Protex Powder consumption and Balya Protex Powder non-consumption group, respectively. Body mass index decreased by 5.93% and 5.18% in the Balya Protex Powder consumption and Balya Protex Powder non-consumption group, respectively. Abdomen girth decreased by 8.39% and 4.67% in the Balya Protex Powder consumption and Balya Protex Powder non-consumption group, respectively. Weakness grade decreased by 83.69% and 47.61% in the Balya Protex Powder consumption and Balya Protex Powder non-consumption group, respectively. All patients showed significant reduction in glycated hemoglobin (HbA1c) levels, however patients in the subgroup who were taking 30 gm of Balya Protex Powder daily showed 50% greater reduction in chronic fatigue score. It can be concluded that Balya Protex Powder consumption leads to good glycemic control with reduced fatigue in diabetic patients whilst adhering to the CDC program.
| Published in | International Journal of Diabetes and Endocrinology (Volume 8, Issue 1) |
| DOI | 10.11648/j.ijde.20230801.14 |
| Page(s) | 16-20 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Ayurveda, Body Mass Index, Diabetes Mellitus, Fatigue, Protein
| [1] | Webber S. International Diabetes Federation. Vol. 102, Diabetes Research and Clinical Practice. 2013. 147–148. |
| [2] | Diabetes DOF. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33 (SUPPL. 1). |
| [3] | Bi Y, Zhang L, Li X, Kan Y, Li S, Zou Y, et al. Contributing factors of fatigue in patients with type 2 diabetes: A systematic review. Psychoneuroendocrinology [Internet]. 2021; 130: 105280. Available from: https://doi.org/10.1016/j.psyneuen.2021.105280 |
| [4] | Lien ASY, Hwang JS, Jiang Y Der. Diabetes related fatigue sarcopenia, frailty. J Diabetes Investig. 2018; 9: 3–4. |
| [5] | Gordon A, Buch Z, Baute V, Coeytaux R. Use of Ayurveda in the treatment of type 2 diabetes mellitus. Glob Adv Heal Med. 2019; 8. |
| [6] | Chattopadhyay K, Wang H, Kaur J, Nalbant G, Almaqhawi A, Kundakci B, et al. Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis. Front Pharmacol. 2022; 13: 1–31. |
| [7] | Sane R. To study efficacy of Comprehensive Diabetes Care (cdc) management program in type II diabetic obese patients: An observational study. Int J Ayurveda Pharma Res. 2018; 6: 6–12. |
| [8] | Sane R. Efficacy of Comprehensive Diabetes Care (CDC) management program in elderly male patients of type II diabetes mellitus: A retrospective Study. Int J Diabetes Endocrinol. 2018; 3: 29. |
| [9] | Shingan TN, Kamlapure S, Kulthe N. Role of Ayurveda Based Comprehensive Diabetic Care Program in Restoration of Euglycemia in known Type 2 Diabetic Mellitus. 2022; 7: 91–5. |
| [10] | Acevedo Martínez KA, Gonzalezde Mejia E. Comparison of five chickpea varieties, optimization of hydrolysates production and evaluation of biomarkers for type 2 diabetes. Food Res Int [Internet]. 2021; 147: 110572. Available from: https://doi.org/10.1016/j.foodres.2021.110572 |
| [11] | Bhagyawant, S. S., Narvekar, D. T., Gupta, N., Bhadkaria, A. G, A., & Srivastava N. Chickpea (Cicer arietinum L.) lectin Alpha-glucosidase, exhibit inhibition of ACE-I alpha-amylase and activity. Protein Pept Lett. 2019; 26: 494–501. |
| [12] | Acevedo Martinez KA, Yang MM, Gonzalez de Mejia E. Technological properties of chickpea (Cicer arietinum): Production of snacks and health benefits related to type-2 diabetes. Compr Rev Food Sci Food Saf. 2021; 20: 3762–87. |
| [13] | Arzati MM, Honarvar NM, Saedisomeolia A, Anvari S, Effatpanah M, Arzati RM, et al. The effects of ginger on fasting blood sugar, hemoglobin A1c, and lipid profiles in patients with type 2 diabetes. Int J Endocrinol Metab. 2017; 15: 131–40. |
| [14] | Li Y, Tran VH, Duke CC, Roufogalis BD. Gingerols of zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes. Planta Med. 2012; 78: 1549–55. |
| [15] | X F Zhang BKT. Effects of an ethanolic extract of Gynura procumbens on serum glucose, cholesterol and triglyceride levels in normal and streptozotocin-induced diabetic rats. Singapore Med J. 200AD; 41: 9–13. |
APA Style
Rohit Sane, Rahul Mandole, Gurudatta Amin, Pravin Ghadigaonkar, Harshita Gupta. (2023). Impact of Balya Protex Powder on Fatigue Levels in Patients with Diabetes Mellitus Adhering to the Ayurveda-Based Comprehensive Diabetic Care Program. International Journal of Diabetes and Endocrinology, 8(1), 16-20. https://doi.org/10.11648/j.ijde.20230801.14
ACS Style
Rohit Sane; Rahul Mandole; Gurudatta Amin; Pravin Ghadigaonkar; Harshita Gupta. Impact of Balya Protex Powder on Fatigue Levels in Patients with Diabetes Mellitus Adhering to the Ayurveda-Based Comprehensive Diabetic Care Program. Int. J. Diabetes Endocrinol. 2023, 8(1), 16-20. doi: 10.11648/j.ijde.20230801.14
AMA Style
Rohit Sane, Rahul Mandole, Gurudatta Amin, Pravin Ghadigaonkar, Harshita Gupta. Impact of Balya Protex Powder on Fatigue Levels in Patients with Diabetes Mellitus Adhering to the Ayurveda-Based Comprehensive Diabetic Care Program. Int J Diabetes Endocrinol. 2023;8(1):16-20. doi: 10.11648/j.ijde.20230801.14
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijde.20230801.14,
author = {Rohit Sane and Rahul Mandole and Gurudatta Amin and Pravin Ghadigaonkar and Harshita Gupta},
title = {Impact of Balya Protex Powder on Fatigue Levels in Patients with Diabetes Mellitus Adhering to the Ayurveda-Based Comprehensive Diabetic Care Program},
journal = {International Journal of Diabetes and Endocrinology},
volume = {8},
number = {1},
pages = {16-20},
doi = {10.11648/j.ijde.20230801.14},
url = {https://doi.org/10.11648/j.ijde.20230801.14},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20230801.14},
abstract = {Chronic fatigue in diabetic patients can be the outcome of protein deficiency. Plant based protein is closer to nature and bodily acceptable, hence we chose to assess plant-based protein “Balya Protex Powder” over whey protein. A prospective, multicentre, post-market study was conducted in India. Patients with a diagnosis of diabetes mellitus aged 18 years and above were included in this study. All patients adhered to the Comprehensive Diabetic Care (CDC) Program. Comparative data of change in fatigue score was collected retrospectively from type 2 diabetes mellitus patients assigned a low carbohydrate low calorie diet for 90 days. A total of 101 patients were included in this study, 50 patients consumed the Balya Protex Powder whilst 51 did not consume the Balya Protex powder whilst adhering to the CDC program. Weight of the patients decreased by 7.92% and 5.52% in the Balya Protex Powder consumption and Balya Protex Powder non-consumption group, respectively. Body mass index decreased by 5.93% and 5.18% in the Balya Protex Powder consumption and Balya Protex Powder non-consumption group, respectively. Abdomen girth decreased by 8.39% and 4.67% in the Balya Protex Powder consumption and Balya Protex Powder non-consumption group, respectively. Weakness grade decreased by 83.69% and 47.61% in the Balya Protex Powder consumption and Balya Protex Powder non-consumption group, respectively. All patients showed significant reduction in glycated hemoglobin (HbA1c) levels, however patients in the subgroup who were taking 30 gm of Balya Protex Powder daily showed 50% greater reduction in chronic fatigue score. It can be concluded that Balya Protex Powder consumption leads to good glycemic control with reduced fatigue in diabetic patients whilst adhering to the CDC program.},
year = {2023}
}
TY - JOUR T1 - Impact of Balya Protex Powder on Fatigue Levels in Patients with Diabetes Mellitus Adhering to the Ayurveda-Based Comprehensive Diabetic Care Program AU - Rohit Sane AU - Rahul Mandole AU - Gurudatta Amin AU - Pravin Ghadigaonkar AU - Harshita Gupta Y1 - 2023/03/24 PY - 2023 N1 - https://doi.org/10.11648/j.ijde.20230801.14 DO - 10.11648/j.ijde.20230801.14 T2 - International Journal of Diabetes and Endocrinology JF - International Journal of Diabetes and Endocrinology JO - International Journal of Diabetes and Endocrinology SP - 16 EP - 20 PB - Science Publishing Group SN - 2640-1371 UR - https://doi.org/10.11648/j.ijde.20230801.14 AB - Chronic fatigue in diabetic patients can be the outcome of protein deficiency. Plant based protein is closer to nature and bodily acceptable, hence we chose to assess plant-based protein “Balya Protex Powder” over whey protein. A prospective, multicentre, post-market study was conducted in India. Patients with a diagnosis of diabetes mellitus aged 18 years and above were included in this study. All patients adhered to the Comprehensive Diabetic Care (CDC) Program. Comparative data of change in fatigue score was collected retrospectively from type 2 diabetes mellitus patients assigned a low carbohydrate low calorie diet for 90 days. A total of 101 patients were included in this study, 50 patients consumed the Balya Protex Powder whilst 51 did not consume the Balya Protex powder whilst adhering to the CDC program. Weight of the patients decreased by 7.92% and 5.52% in the Balya Protex Powder consumption and Balya Protex Powder non-consumption group, respectively. Body mass index decreased by 5.93% and 5.18% in the Balya Protex Powder consumption and Balya Protex Powder non-consumption group, respectively. Abdomen girth decreased by 8.39% and 4.67% in the Balya Protex Powder consumption and Balya Protex Powder non-consumption group, respectively. Weakness grade decreased by 83.69% and 47.61% in the Balya Protex Powder consumption and Balya Protex Powder non-consumption group, respectively. All patients showed significant reduction in glycated hemoglobin (HbA1c) levels, however patients in the subgroup who were taking 30 gm of Balya Protex Powder daily showed 50% greater reduction in chronic fatigue score. It can be concluded that Balya Protex Powder consumption leads to good glycemic control with reduced fatigue in diabetic patients whilst adhering to the CDC program. VL - 8 IS - 1 ER -
Information
Email: